Peroxiredoxin-4 and beta-hydroxybutyrate after SGLT2 inhibitor treatment in heart failure with preserved ejection fraction
17 May 2025 (08:00 - 12:45)
Organised by: 
About the speaker
Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
3 More presentations in this session
Associate Professor A. Briasoulis (Athens, GR)
Assistant Professor M. Pandrc (Belgrade, RS)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025
You may be interested in
Congress Presentation
Congress Presentation
